Pirbright is developing several livestock vaccines to protect against zoonotic diseases and prevent their transmission to humans. Researchers are testing vaccines for Nipah virus in pigs and Crimean-Congo haemorrhagic fever (CCHF) in sheep. They are also developing a universal influenza vaccine and using modelling to predict disease spread. Climate change is enabling some diseases to spread further as rising temperatures allow insect vectors to survive at higher latitudes, potentially increasing risks like CCHF transmission by ticks in the UK.
Pirbright is developing several livestock vaccines to protect against zoonotic diseases and prevent their transmission to humans. Researchers are testing vaccines for Nipah virus in pigs and Crimean-Congo haemorrhagic fever (CCHF) in sheep. They are also developing a universal influenza vaccine and using modelling to predict disease spread. Climate change is enabling some diseases to spread further as rising temperatures allow insect vectors to survive at higher latitudes, potentially increasing risks like CCHF transmission by ticks in the UK.
Pirbright is developing several livestock vaccines to protect against zoonotic diseases and prevent their transmission to humans. Researchers are testing vaccines for Nipah virus in pigs and Crimean-Congo haemorrhagic fever (CCHF) in sheep. They are also developing a universal influenza vaccine and using modelling to predict disease spread. Climate change is enabling some diseases to spread further as rising temperatures allow insect vectors to survive at higher latitudes, potentially increasing risks like CCHF transmission by ticks in the UK.
Scientists are developing several different vaccines that Viruses that spread from animals to people will protect livestock from zoonoses, and so help prevent these animals from transmitting the viruses to humans. We are collaborating internationally to produce an inexpensive, safe and effective vaccine to protect pigs against Nipah. Aedes aegypti female feeding
To combat CCHF, researchers
are conducting a series of Predicting new threats field studies to test whether Predicting where the next virus will emerge from, or how an a vaccine developed by existing virus might mutate to transmit between animals or Public Health England prevents humans more efficiently, is a crucial part of disease control. infection in sheep, to get a better understanding of the disease dynamics and Pirbright scientists use complex mathematical modelling get reliable estimates of the virus prevalence in the incorporating data from the Met Office to investigate how unvaccinated population to inform the vaccine trial. weather patterns influence the movement and transmission of diseases. This provides valuable insight into how some Scientists are also developing a new universal vaccine to airborne diseases may interact with the atmosphere protect against all strains of influenza virus. This is extremely and the movement of vectors that transmit disease. challenging due to the number of strains of flu virus circulating and the emergence of new strains. Currently we are testing an S-FLU aerosol vaccine, developed by Alain The role of climate change Townsend at Oxford. The pig immune and respiratory Rising temperatures across Europe are systems are very similar to humans so may provide a one of the driving forces that allows diseases better model for infection and vaccination studies. to travel further north from southern Europe and Africa. The insect vectors that carry these diseases are then able to survive Vector control at higher latitudes for longer, increasing Mosquitoes carry and transmit many deadly diseases their ability to spread disease. that result in millions of deaths. Hyalomma ticks, the vector for CCHF, are We are studying the ability of European mosquitoes highly adapted to warm and dry conditions to transmit RVF virus as well as understanding how and if these conditions become more widespread susceptible European livestock breeds are to the disease. populations of these ticks are likely to become established, This will reveal how big a threat RVF poses in Europe and bringing with them the risk of CCHF to humans. enable us to predict how an outbreak may spread. UK ticks are unable to transmit CCHF to humans, We are also exploring ways in which genetically modified but a changing climate could increase the risk of (GM) mosquitoes could be used to control populations Hyalomma ticks moving and living further north. and help prevent the spread of zoonoses. Modifying Migratory birds and horses can transport the tick into male Aedes mosquitoes to produce sterile offspring new areas and by 2080 the conditions may be warm enables targeted suppression of the population. These enough for them to survive in the UK. methods could be employed to tackle a variety of insect borne diseases such as RVF, Zika and malaria. We use the latest GM techniques for controlling mosquito-spread diseases, including CRISPR/Cas9 and gene drives that only control populations locally. www.pirbright.ac.uk/zoonoses Preventing and controlling viral disease ZOONOTIC DISEASES – KEY FACTS Zoonotic diseases are infections Scientists estimate that 6 out of 10 human Viral zoonoses are spread directly In 2018 the World Health Organization caused by viruses, bacteria and infectious diseases come from animals, through contact with saliva, (WHO) released a list of priority diseases parasites that spread between animals and 3 out of 4 new infectious diseases blood, urine or other bodily fluids based on their potential to become pandemic and people. They can make people are spread from animals to people. With of an infected animal, by airborne and the lack of robust control measures. All and animals very sick, and can be increased global movement of people means (influenza) or indirectly ten diseases on the list are caused by viral fatal. Pirbright scientists study viral and animals and human activity close to (vector borne) via bites from a zoonoses. These include viruses like Crimean- zoonotic diseases to try and find animal habitats, controlling and predicting tick or an insect, for example such Congo haemorrhagic fever (CCHF), Ebola, ways to stop them spreading. diseases is a priority. as a flea or mosquito (Zika). Nipah, Rift Valley fever, Zika and Disease X.
WHAT ARE VIRAL ZOONOSES? PIRBRIGHT’S RESEARCH
Zoonoses affect a wide range of species and have Our scientists study a range of viral zoonoses: a huge impact on animal and human health, as • C rimean-Congo haemorrhagic fever (CCHF) infects well as food and economic security. At Pirbright both wild and domestic animals, such as cattle, sheep we study viral zoonoses, the insects that spread and goats, and humans. Infection is caused by a bite these diseases (known as vectors) and we develop from an infected tick (Hyalomma) or being exposed vaccines to control them. to the blood or fluids of infected animals or humans. Some zoonoses have re-emerged to cause epidemics 10-40% of people who develop haemorrhagic fever after infection are likely to die from the disease. resulting in widespread suffering and global concern. MAKING THE LEAP Most recent examples include the 2013 outbreak of • R ift Valley fever (RFV) affects sheep, cattle and goats. Ebola virus disease which spread throughout West Health experts and scientists worry that the next It is transmitted by mosquitoes but it can also be spread global pandemic could be caused by a new or Africa until it was successfully controlled in 2016 – through direct contact with infected animals and meat. re-emerging zoonosis. over 11,000 people died as a result. Ebola has since In severe cases, the human fatality rate may be 10-20%. re-emerged in the Democratic Republic of Congo. Zoonoses are often transferred from animal to human by • A vian influenza viruses (bird flu) have a natural a change in the genetic structure of the virus, for example reservoir in wild birds such as ducks. The H5N1 and Another zoonosis which is transmitted by infected both SARS and Middle East respiratory syndrome (MERS) H7N9 strains can cause severe disease and have a mosquitoes (Aedes) is Zika virus which, although causes coronaviruses are thought to have been caused by a only mild symptoms in the majority of people, can cause high mortality rate in people. genetic mutation that enabled them to jump species. microcephaly in foetuses and result in Guillain-Barré Changes in environment, climate and geography can • S wine influenza viruses infect a wide range of syndrome, neuropathy and myelitis in children and adults. also play a part – deforestation destroys areas leading animals, but are most commonly present in pigs. Rift Valley fever, to once remote habitats being invaded by humans who In 2009 the H1N1 strain caused a global outbreak Nipah, severe are then more likely to be exposed to new infections. in humans killing over 18,000 people. acute respiratory However, it is often unclear why some diseases mutate into deadly viruses and each new threat poses further • N ipah virus has a mortality rate of up to 40% in syndrome (SARS), people. Fruit bats are the natural reservoir but it challenges for science and public health. and avian and also infects pigs, which are more likely to spread swine influenza the disease to humans. Transmission of Nipah virus viruses are also CONTROLLING ZOONOSES between humans, pigs and bats is through direct examples of viral It takes time and money to develop vaccines to control contact with excretions like bat urine. zoonoses that new diseases therefore resources are targeted at those have either caused diseases that have the potential to spread rapidly causing • C hikungunya virus is mosquito borne and found in or have the potential severe infections. Affected countries also work together to monkeys, birds, cattle, and rodents but it also infects to cause serious global scan for new outbreaks, track the spread and use this data people. Symptoms include a short fever followed by pandemics and they Scanning electron micrograph of to map zoonotic diseases and inform control strategies. severe joint pains that can persist for years. continue to pose Ebola virus Makona (in red) from the West African epidemic shown on the a threat. surface of Vero cells (blue). Credit: NIAID